Clinical Trial

Surgery for Locally Unresectable Pancreatic Cancer

Study acronym: ROBIN
Recruiting
View on ClinicalTrials.gov →
Summary
Pancreatic cancer is a severe disease often diagnosed at an advanced stage, when surgery is not possible. New chemotherapy treatments can sometimes shrink the tumor and make surgery an option. This study aims to understand if surgery after such treatments can improve survival and quality of life in selected patients treated at expert centers.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-17.
Trial Details
NCT Number NCT07241663
Lead Sponsor Azienda Ospedaliera di Padova
Collaborators: University of Padova
Conditions Locally Advanced Pancreatic Adenocarcinoma
Enrollment 150 participants
Start Date 2025-01-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-11-26